QUOTIENT SCIENCES LIMITED sell "Bioanaysis"

Bioanalysis is a critical step in drug development, and Quotient specializes in developing, validating, and applying bioanalytical assays. Its bioanalytical chemists, globally recognized with over 40 years of combined experience, support every stage from early preclinical work through First-in-Human and Phase I-III studies, delivering rapid results via LC-MS/MS, ICP-MS/MS, GC-MS/MS, and high-resolution mass spec (LC-TRAP-MS and LC-TOF-MS). Turnaround for preclinical and clinical samples is fast, with an even quicker 72-hour Priority Analysis option, supported by GLP- and GCP-accredited laboratories with global regulatory compliance (FDA, EMEA, MHRA) and specialist expertise including insulin analogues and polypeptide drugs by LC-MS/MS, elemental analysis by ICP-MS, and volatile drug/biomarker analysis.